freephone 0800 862 0373
Sign in to view your quotes
Email address:
Password or PIN:

Forgotten your password? Reset it here.

NICE denies access to bowel cancer drug for NHS patients

Published on 25/08/2010
More people may be tempted to take out private medical cover in order to gain access to the latest medicines following the latest decision from the National Institute for Health and Clinical Excellence (NICE).

The body, which regulates treatments available on the NHS, has decided that a drug to treat advanced bowel cancer should not be made available to NHS patients.

That is because bevacizumab, commonly known as Avastin, is deemed too expensive compared to the potential benefits it could bring.

It is estimated that approximately 6,500 people per year might be eligible for the drug, which costs around £20,800 per patient.

Charity Bowel Cancer UK said it is "naturally disappointed" that NICE decided not too approve the drug when "there is so much evidence of the treatment's efficacy and it is so widely available to patients across the rest of Europe".

Rob Glynne Jones, chief medical adviser at Bowel Cancer UK, said that UK patients with advanced bowel cancer survive for an average of 19 months, compared to up to 27 months for patients in countries that use Avastin.

Bowel cancer is the third most common cancer in the UK, with more than 38,600 people diagnosed with the disease every year.
© ActiveQuote Ltd. 2010


Categories:
NICE denies access to bowel cancer drug for NHS patientsMore people may be tempted to take out private medical cover in order to gain access to the latest medicines following the latest decision f    tweet it on twittershare with your friends on Facebookshare with your friends on MySpaceBlog it on your LinkedIn profile
 

No.1 health insurance broker as rated by customers

Good value and the advisor was very helpful and recommended the best policy for my grandson. I would definitely use this service again and recommend to others.

Review centre member

We were contacted in good time to make a knowledgable choice. We were given plenty of options with lots of information to enable us to make the right choice.

Review centre member

The service I received was excellent, the staff member was very efficient and knowledgable. She went out of her way to get the best policy for me.

Review centre member

Great service. I really appreciated the help provided by Active Quote to arrange health insurance. The agent was very informative and proactive. Many thanks!

Review centre member

I received excellent care and attention from the first phone call till the last. Friendly, efficient and patient.

Review centre member

Staff are very helpful, friendly and polite. They call back when they say they will and keep you up to date with progress. Pleasure to deal with.

Review centre member

Very polite and friendly, and gave detailed explanations of all aspects of the cover. Reassuring to know that if you do have a problem there is someone you can contact.

Review centre member

Friendly and efficient. Nothing was too much trouble even when i needed to make a small change, excellent service.

Review centre member

The advisor was incredibly helpful and fully explained the differences between the policies. I really liked the fact that I was put under no pressure.

Review centre member

I was pleasantly surprised with the in-depth knowledge, the efficiency and the nice and polite manner of the staff - the explanations were made very clearly.

Review centre member
 
This site is operated by Insurance Broker ActiveQuote Ltd registered in England & Wales company number 6765845.
Authorised and Regulated by the Financial Conduct Authority (FCA). Firm reference number 501109 as detailed on the Financial Services Register. Please read our Key Facts document.
For information about your rights as a consumer visit Citizens Advice.

Our insurance comparison service is free and easy for you to use, but you are responsible for making sure all your information is entered correctly, and for choosing your insurer.

This site uses cookies in order to work correctly - these are not harmful and do not contain personal information. By using this site you consent to this. I understand  Tell me more

please wait ...